CATALYS PACIFIC
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm's mission is to focus on providing healthcare solutions for patients worldwide through the creation of and investment in bioventure companies. Catalys Pacific is led by a global team versed in working closely with its partners in academia, biotech, venture capital and the pharmaceutical industry in Japan and worldwide. The firm maintains offices in Tokyo and Kanagawa (Shonan Health Innovation Park), Japan and in Seattle, Washington.
CATALYS PACIFIC
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-08 | Mineralys Therapeutics | Catalys Pacific investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-03-28 | Aculys Pharma | Catalys Pacific investment in Series B - Aculys Pharma | 2.8 B JPY |
| 2021-10-28 | Aculys Pharma | Catalys Pacific investment in Series A - Aculys Pharma | 6.8 B JPY |
| 2021-09-08 | HilleVax | Catalys Pacific investment in Venture Round - HilleVax | 135 M USD |
| 2021-06-22 | Pathalys Pharma | Catalys Pacific investment in Seed Round - Pathalys Pharma | 11 M USD |
| 2021-04-06 | Mineralys Therapeutics | Catalys Pacific investment in Seed Round - Mineralys Therapeutics | 4 M USD |
| 2021-04-06 | Mineralys Therapeutics | Catalys Pacific investment in Series A - Mineralys Therapeutics | 40 M USD |
| 2020-07-16 | Exalys Therapeutics | Catalys Pacific investment in Series A - Exalys Therapeutics | 15 M USD |
| 2019-05-15 | Phathom Pharmaceuticals | Catalys Pacific investment in Private Equity Round - Phathom Pharmaceuticals | 90 M USD |
More informations about "Catalys Pacific"
Catalys Pacific - Crunchbase Investor Profile
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm's mission is to focus on providing healthcare solutions for patients worldwide through the creation of …See details»
Catalys Pacific - LinkedIn
Catalys Pacific begins operations as one of Japanʼs largest life sciences-focused investment firms. The firmʼs mission is to provide solutions to unmet medical needs for patients worldwide by ...See details»
Catalys Pacific - CoBee Company Profile & Funding Rounds
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm&s;s mission is to focus on providing healthcare solutions …See details»
Catalys Pacific - The Org
Catalys Pacific begins operations as one of Japanʼs largest life sciences-focused investment firms. The firmʼs mission is to provide solutions to unmet medical needs for patients worldwide by creating and investing in companies that drive …See details»
Charter - Catalys Pacific
Improving patient lives worldwide by driving impact and innovation in healthcare and contributing to advancements in life sciences.See details»
Catalys Pacific - VentureRadar
Catalys Pacific specializes in creating and developing bespoke biotech companies through strategic transpacific partnerships. Leveraging a robust global network and local presence in …See details»
Catalys Pacific - Investments, Portfolio & Company Exits
Catalys Pacific has invested in Phathom Pharmaceuticals on Aug 20, 2024. This investment - Private Equity Round - Phathom Pharmaceuticals - was valued at . obfuscated. obfuscated. …See details»
The Japan Kidney Association and Renalys Pharma …
May 7, 2024 The Japan Kidney Association is an organization established to overcome kidney disease through collaboration between medical professionals, citizens, related companies, government, and others. ... The company was …See details»
Catalys Pacific investment portfolio - PitchBook
Catalys Pacific General Information Company Description. Founded in 2019, Catalys Pacific is a venture capital firm based in Tokyo, Japan. The firm seeks to invest in healthcare, pharmaceuticals & biotechnology, and life sciences …See details»
[8 Steps] Catalys Pacific Case Study Solution
Nov 3, 2024 Catalys Pacific is a multinational corporation operating in the emerging markets with a focus on manufacturing and distribution of consumer goods. The company faces challenges …See details»
Catalys Pacific - Funding, Financials, Valuation & Investors
Catalys Pacific has raised a total of $170M in a single venture fund, Catalys Pacific Fund, LP. This fund was announced on Jul 30, 2018 and raised a total of . obfuscated. obfuscated. Unlock for …See details»
Catalys Pacific - Case - Harvard Business School
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the …See details»
People - Catalys Pacific
Catalys Pacific’s “on-the-ground” investment team brings together dedicated R&D experts & advisors, local sourcing partners & institutions combined with broad syndicate relationships. …See details»
Founder & Managing Partner @ Catalys Pacific - Crunchbase
BT Slingsby, MD, PhD, MPH is Founder and Managing Partner with Catalys Pacific. He founded Catalys Pacific to transform life-sciences innovation in Japan using transpacific bioventure. BT …See details»
Catalys Pacific | Harvard Business Publishing Education
Catalys Pacific's early challenges prompt students to evaluate what features of the business environment are critical for venture capital generally, and venture creation funds specifically, to …See details»
Catalys Pacific - Updates, News, Events, Signals & Triggers
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Creations - Catalys Pacific
We are an “on-the-ground” investment team with dedicated R&D experts and advisors, local sourcing partners and institutions combined with broad syndicate relationships.See details»
Catalys Pacific - Contacts, Employees, Board Members
Catalys Pacific has 6 current employee profiles, including Associate Reika Okada. Catalys Pacific has 7 board members and advisors, including Jon Congleton. Contacts. Edit Contacts Section. …See details»
Perspectives - Catalys Pacific
Jun 19, 2019 News and resources from Catalys Pacific. Transposon Announces Final Results from a Phase 2 Study of its LINE-1 Reverse Transcriptase Inhibitor TPN-101 for the Treatment …See details»